Saptrax SB 500mg/250mg Injection
Marketer
Sapson Pharma
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Saptrax SB 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic, indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thus controlling infection spread. Administration of Combiflox 500mg/250mg Injection must be strictly under medical guidance. Consistent adherence to the prescribed dosage schedule is crucial; completing the full course is vital, regardless of symptom improvement. Premature cessation may compromise therapeutic efficacy. Commonly reported side effects include gastrointestinal upset (nausea, vomiting, diarrhea, dyspepsia). Worsening side effects necessitate immediate physician consultation. Seek emergency medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress). Prior to commencing treatment, inform your doctor of all current medications and pre-existing conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Ensure adequate rest, balanced nutrition, and sufficient hydration for optimal recovery. Your doctor may order lab tests to monitor treatment efficacy.
Uses of Saptrax SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Saptrax SB 500mg/250mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Saptrax SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Saptrax SB 500mg/250mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Saptrax SB 500mg/250mg Injection works:
The injectable formulation Saptrax SB (500mg Ceftriaxone/250mg Sulbactam) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action disrupts bacterial cell wall synthesis, hindering their growth. Sulbactam's role is to counter bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Saptrax SB 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Saptrax SB 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human studies remain scarce.
Breast feedingCAUTION
The administration of Saptrax SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the course of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The Saptrax SB 500mg/250mg Injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Saptrax SB 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The use of Saptrax SB 500mg/250mg Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Saptrax SB 500mg/250mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Saptrax SB 500mg/250mg Injection :
Omit a Saptrax SB 500mg/250mg Injection dose? Seek medical advice immediately.
Facts to Know About Saptrax SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently